On 17 June, REVERA Law Group invites pharmaceutical companies to a business breakfast on permanent establishments and monitoring the presence of foreign companies.
The event is closed‑door.
During the meeting, REVERA Law Group experts will outline practical steps on:
1. how to determine the boundary between a non‑commercial presence and a permanent establishment,
2. which indicators regulatory authorities monitor, and
3. how to safely structure a presence model.
